Real-World Effectiveness From the Asia Pacific Rim Liver Consortium for HBV Risk Score for the Prediction of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated With Oral Antiviral Therapy

Hwai‐I Yang(Chang Gung University), Mindie H. Nguyen(Stanford Medicine), Rui Huang(Nanjing University of Chinese Medicine), Jia Shang(European Foundation for the Study of Chronic Liver Failure), Chao Wu(Beijing Tongren Hospital), Hidenori Toyoda(Ogaki Municipal Hospital), Jian Q. Zhang, Eiichi Ogawa(Kyushu University Hospital), Chenghai Liu(Shanghai University of Traditional Chinese Medicine), Shinji Iwane(Saga University), Joseph Hoang(Stanford University), Tatsuya Ide(Kurume University), Ritsuzo Kozuka(Osaka City University), Ming‐Lun Yeh(Kaohsiung Medical University), Christopher K. Wong(University of California, Santa Cruz), Yuichiro Eguchi(Saga University), Ka Shing Cheung(University of Auckland), Jia‐Horng Kao(National Taiwan University Hospital), Cheng‐Yuan Peng(China Medical University), An K. Le(Stanford University), Man‐Fung Yuen(University of Hong Kong - Shenzhen Hospital), Yoshiyuki Ueno(Yamagata Prefectural University of Health Sciences), Norihiro Furusyo(Kyushu University Hospital), Linda Henry(Center for Outcomes Research in Liver Diseases), Ming‐Lung Yu(National Sun Yat-sen University), Qing Xie(Ruijin Hospital), Chia‐Hsin Lin(Chang Gung University), Huichun Xing(Capital Medical University), Masayuki Kurosaki(Musashino Red Cross Hospital), Huibin Ning(Henan Provincial People's Hospital), Grace Lai‐Hung Wong(Chinese University of Hong Kong), Edward Gane(University of Auckland), Masaru Enomoto(Osaka City University), Dong-Hyun Lee, Jiayi Li(Northeastern University), Hirokazu Takahashi, Clifford Wong, Changqing Zhao(Shanghai University of Traditional Chinese Medicine), Chien‐Hung Chen(Chang Gung University), Huy N. Trinh, Tung‐Hung Su(National Taiwan University)
The Journal of Infectious Diseases
September 13, 2019
Cited by 101


Related Papers